Recombinant Human B-lymphocyte antigen CD19 (CD19), partial (Active)
Product Specifications
Product Name Alternative
B-Lymphocyte Antigen CD19; B-Lymphocyte Surface Antigen B4; Differentiation Antigen CD19; T-Cell Surface Antigen Leu-12; CD19
Abbreviation
Recombinant Human CD19 protein, partial (Active)
Gene Name
CD19
UniProt
P15391
Expression Region
20-291aa
Organism
Homo sapiens (Human)
Target Sequence
Tag
C-terminal Fc-tagged
Type
Active Protein & In Stock Protein
Source
Mammalian cell
Field of Research
Immunology
Relevance
Endotoxin
Less than 1.0 EU/μg as determined by LAL method.
Purity
Greater than 95% as determined by SDS-PAGE.
Activity
Yes
Bioactivity
Form
Lyophilized powder
Buffer
Lyophilized from a 0.2 μm filtered 20 mM PB, 150mM NaCl, pH 7.4
Reconstitution
Function
Assembles with the antigen receptor of B-lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
Molecular Weight
57.3 kDa
Storage Conditions
Product MSDS
https://www.cusabio.com/msds/12923638/
Protein Length
Extracellular Domain
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items